Dikhyaa Mohanty 
In an effort to eradicate lymphatic filariasis (LF), the Odisha Health and Family Welfare Department will launch a Mass Drug Administration (MDA) campaign in six endemic districts: Balangir, Kalahandi, Rayagada, Cuttack, Kandhamal, and Nayagarh, from February 10 to 19. To prepare for this, the agency held a state-level media sensitization workshop in Bhubaneswar with Global Health Strategies to increase knowledge of LF, its crippling consequences, and the significance of medicine administration.
All eligible people in these districts will get anti-filarial medication under the supervision of qualified health workers during the campaign. The dosage is not required for seriously ill patients, pregnant women, or children under the age of two. In order to make the eradication of filariasis a public movement, officials, health professionals, the community, and public representatives must collaborate, stressed Dr. Bijay Kumar Mahapatra, Special Secretary and Director of Health Services.
Additionally, Special Secretary Dr. Jitendra Kumar Bebarta emphasized that the illness may be eliminated with the cooperation of the media and the society, and that high drug use rates will aid in breaking the cycle of transmission. According to Dr. Neelkantha Mishra, director of public health, LF is a mosquito-borne illness that is one of the main causes of long-term disability globally. If left untreated, it can cause irreparable swelling of bodily parts and is frequently acquired in childhood and presents in maturity. Conditions including hydrocele (scrotal inflammation), lymphoedema (limb swelling), and chyluria (milky white urine) are common in filariasis patients.
He promised that anti-filarial medications are well-researched, safe, and seldom cause adverse effects. Each block will have Rapid Response Teams under the direction of medical professionals to handle any negative responses.
Integrated vector control, high-level advocacy involving multiple ministries like Panchayati Raj and Urban & Rural Development, mass drug administration to prevent transmission, morbidity management and disability prevention through home-based care and surgical interventions, and the use of cutting-edge digital platforms for surveillance and diagnostics are the five pillars of India’s National Programme for Elimination of Lymphatic Filariasis.
